IL1A and Hepatic failure: On the basis of these findings, it appears likely that prevention of the inflammatory effects of pro-inflammatory cytokines such as IL-1 are critical for preventing tissue and engrafted-cell damage and increasing survival rates in early phases of hepatic failure.